Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Arzerra1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
2ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
3ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4Arzerra®1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5Combination Product: ofatumumab with AI
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
6Combination Product: ofatumumab with PRF
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
7Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
(Arzerra (TN))		12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab (Arzerra),
Ponesimod,
Rituximab,
Teriflunomide		10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab (Arzerra (TN)),
Fingolimod ,
Teriflunomide ,
Ponesimod 💬		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬1件: 13 💬
8OFATUMUMAB
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 35, 46 💬
9Ofatumumab 100
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
10Ofatumumab 300
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
11Ofatumumab 30mg
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
12Ofatumumab 3mg
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
13Ofatumumab 60mg
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
14Ofatumumab 700
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
15Ofatumumab subcutaneous injection
(Arzerra (TN))		1件: Ofatumumab (Arzerra)1件: Ofatumumab (Arzerra (TN)) 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬